Provided by Tiger Trade Technology Pte. Ltd.

Health Care Select Sector SPDR Fund

166.18
-0.0200-0.01%
Post-market: 166.190.0101+0.01%19:55 EDT
Volume:7.15M
Turnover:1.19B
Market Cap:42.64B
PE:-11.69
High:166.85
Open:166.55
Low:165.27
Close:166.20
52wk High:176.60
52wk Low:141.05
Shares:256.62M
Float Shares:256.62M
Volume Ratio:0.83
T/O Rate:2.79%
Dividend:2.45
Dividend Rate:1.47%
EPS(TTM):-14.2170
EPS(LYR):-14.2170
ROE:-9.22%
ROA:1.03%
PB:1.24
PE(LYR):-11.69

Loading ...

Fisher & Paykel Healthcare Executive Adjusts Shareholding Through September Sale

TIPRANKS
·
Sep 25

Sonic Healthcare Updates Share Registry Address for Investors

TIPRANKS
·
Sep 25

HealthCo Healthcare & Wellness REIT issues 2026 annual report to unitholders

TIPRANKS
·
Sep 25

Ramsay Health Care sets 2026 AGM and flags Ramsay Santé demerger vote

TIPRANKS
·
Sep 25

Viemed President Adopts Structured Share Sale Plan Under Rule 10b5-1

TIPRANKS
·
Sep 25

Ramsay Health Care Publishes 2026 Corporate Governance Statement

TIPRANKS
·
Sep 25

Ramsay Health Care Sets Out Strategy and Performance in 2026 Annual Report

TIPRANKS
·
Sep 25

Epsilon Healthcare Clarifies Managing Director Loan Was Unsecured

TIPRANKS
·
Sep 25

Analysts Are Bullish on Top Healthcare Stocks: Arcus Biosciences (RCUS), Prime Medicine, Inc. (PRME)

TIPRANKS
·
Sep 25

Healthcare Stocks Rise Despite Broad Market Selloff

Dow Jones
·
Sep 25

Molina Healthcare Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 25

Estee Lauder Cos. Cl a Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 25

HCA Healthcare Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Sep 25

Nanobiotix advances cancer nanotherapeutics and bolsters cash runway into 2029

TIPRANKS
·
Sep 25

France's Nanobiotix H1 Net Loss Widens on Lower Revenue, Absence of 2025 One-Off Gain

Reuters
·
Sep 25

Press Release: Nanobiotix Provides First Half 2026 Operational and Financial Update

Dow Jones
·
Sep 25

FDA approves Welireg and Lenvima combo for ccRCC

TIPRANKS
·
Sep 25

Merck Shares Flat in Volume Spike After FDA Approves Kidney Drug, Last up 0.50% at $148.81

THOMSON REUTERS
·
Sep 25

FDA Approves Belzutifan in Combination with Lenvatinib for Advanced Renal Cell Carcinoma with a Clear Cell Component

THOMSON REUTERS
·
Sep 25

Exchange-Traded Funds Mixed, US Equities Decline After Midday

MT Newswires Live
·
Sep 25